YOKOHAMA CITY UNIVERSITY

YOKOHAMA CITY UNIVERSITY logo
πŸ‡―πŸ‡΅Japan
Ownership
Private
Established
1882-01-01
Employees
-
Market Cap
-
Website
http://www.yokohama-cu.ac.jp

Efficacy and Safety of Pemafibrate for Nonalcoholic Fatty Liver Disease

First Posted Date
2024-10-02
Last Posted Date
2024-10-02
Lead Sponsor
Yokohama City University
Target Recruit Count
360
Registration Number
NCT06623539
Locations
πŸ‡―πŸ‡΅

Yokohama city university, Yokohama, Kanagawa, Japan

Elobixibat for Chronic Constipation Without Defecation Desire

Phase 4
Conditions
Interventions
First Posted Date
2021-12-21
Last Posted Date
2022-03-23
Lead Sponsor
Yokohama City University
Target Recruit Count
40
Registration Number
NCT05165199
Locations
πŸ‡―πŸ‡΅

Yokohama City University, Yokohama, Kanagawa, Japan

Efficacy and Safety of Guanabenz for Nonalcoholic Fatty Liver Disease

Phase 2
Active, not recruiting
Conditions
First Posted Date
2021-10-19
Last Posted Date
2022-09-27
Lead Sponsor
Yokohama City University
Target Recruit Count
29
Registration Number
NCT05084404
Locations
πŸ‡―πŸ‡΅

Yokohama City University, Yokohama, Kanagawa, Japan

Long-term Elobixibat for Chronic Constipation

Phase 4
Recruiting
Conditions
Interventions
First Posted Date
2021-03-05
Last Posted Date
2023-01-05
Lead Sponsor
Yokohama City University
Target Recruit Count
100
Registration Number
NCT04784780
Locations
πŸ‡―πŸ‡΅

Yokohama City University, Yokohama, Kanagawa, Japan

Efficacy and Safety of Rifaximin for Patients With Chronic Intestinal Pseudo-obstruction: a Phase 2 Trial

First Posted Date
2019-10-08
Last Posted Date
2021-06-21
Lead Sponsor
Yokohama City University
Target Recruit Count
12
Registration Number
NCT04118699
Locations
πŸ‡―πŸ‡΅

Yokohama city university, Yokohama, Kanagawa, Japan

Shared Decision Making for Patients With First-admission Schizophrenia

Phase 2
Completed
Conditions
Interventions
First Posted Date
2013-06-05
Last Posted Date
2015-12-30
Lead Sponsor
Yokohama City University
Target Recruit Count
23
Registration Number
NCT01869660
Locations
πŸ‡―πŸ‡΅

Numazu Chuou Hospital, Numazu, Shizuoka, Japan

S-1 or Tegafur-Uracil in Treating Patients With Previously Treated Stage III or Stage IV Head and Neck Cancer

Phase 3
Conditions
First Posted Date
2006-06-15
Last Posted Date
2013-05-15
Lead Sponsor
Yokohama City University
Target Recruit Count
500
Registration Number
NCT00336947
Locations
πŸ‡―πŸ‡΅

National Hospital Organization - Himeji Medical Center, Himeji-shi, Hyogo, Japan

πŸ‡―πŸ‡΅

Fujita Health University, Toyoake, Aichi, Japan

πŸ‡―πŸ‡΅

Mie University Graduate School of Medicine, Tsu, Mie, Japan

and more 45 locations
Β© Copyright 2024. All Rights Reserved by MedPath